Evidence map›Paper›PMID 36625660›Full record

ArticleMicrobiology spectrum2023

Chenodeoxycholic Acid-Amikacin Combination Enhances Eradication of Staphylococcus aureus.

Kaiyu Cui, Weifeng Yang, Zhiyuan Liu, Guijian Liu, Dongying Li, Yanan Sun, Gaiying He, Shuhua Ma, Yu Cao, Xuefan Jiang and 4 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kaiyu Cui *Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China.
Weifeng Yang *Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China.
Zhiyuan LiuGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Guijian LiuGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Dongying LiExperimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China.
Yanan SunExperimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China.
Gaiying HeExperimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China.
Shuhua MaExperimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China.
Yu CaoXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Xuefan JiangBeijing University of Chinese Medicine, Beijing, China.
Sylvie ChevalierNormandy University, University of Rouen Normandy, Laboratory of Microbiology Signals and Microenvironment, Evreux, France.ORCID 0000-0001-6489-438X
Pierre CornelisNormandy University, University of Rouen Normandy, Laboratory of Microbiology Signals and Microenvironment, Evreux, France.
Qing WeiNanchang Institute of Technology, Nanchang, Jiangxi, China.ORCID 0000-0002-6956-6294
Yi WangExperimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rise of antibiotic resistance and dearth of novel antibiotics have posed a serious health crisis worldwide. In this study, we screened a combination of antibiotics and nonantibiotics providing a viable strategy to solve this issue by broadening the antimicrobial spectrum. We found that chenodeoxycholic acid (CDCA), a cholic acid derivative of the traditional Chinese medicine (TCM) Tanreqing (TRQ), synergizes with amikacin against Staphylococcus aureus

Indexed as

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAmikacinAminoglycosidesAnimalsAnti-Bacterial AgentsMiceMicrobial Sensitivity TestsReactive Oxygen SpeciesStaphylococcus aureusSuperoxide DismutaseAmikacinAminoglycosidesAnti-Bacterial AgentsReactive Oxygen SpeciesSuperoxide Dismutaseantibiotic resistancechenodeoxycholic aciddual mechanismStaphylococcus aureustraditional Chinese medicine

Identifiers

PMID36625660
PMCPMC9927322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.